Company: LBRX
Filing Date: 2025-08-22
Form Type: S-1
Source: 0001193125-25-186467
Chunk: 121

Company: LB PHARMACEUTICALS INC
Filing Date: 2025-08-22
Form: S-1
Chunk 121
---
 annual meeting, including 
 proposed nominations of persons for election to our board of directors;                                           |

| • |     | establish that our board of directors is divided into three classes, with each class serving three-year staggered 
 terms;                                                                                                            |

| • |     | prohibit cumulative voting in the election of directors, therefore allowing the holders of a majority of the                                        
 shares of common stock entitled to vote in any election of directors to elect all of the directors standing for election, if they should so choose; |

| • |     | provide that our directors may be removed for cause only upon the vote of at least 66 2/3% of our outstanding 
 shares of voting stock;                                                                                       |

| • |     | provide that vacancies on our board of directors may be filled only by a majority of directors then in office, 
 even though less than a quorum; and                                                                            |

| • |     | require the approval of our board of directors or the holders of at least 66 2/3% of our outstanding shares of 
 voting stock to amend our bylaws and certain provisions of our certificate of incorporation.                   |

These provisions may frustrate or prevent any attempts by our stockholders to replace or remove our current management by making it more difficult for stockholders to replace members of our board of directors, which is responsible for appointing the members of our management. In addition, because we are incorporated in Delaware, we are governed by the provisions of Section 203 of the Delaware General Corporation Law, or DGCL, which generally, subject to certain exceptions, prohibits a Delaware corporation from engaging in any of a broad range of business combinations with any “interested” stockholder for a period of three years following the date on which the stockholder became an “interested” stockholder. Any of the foregoing provisions could limit the price that investors might be willing to pay in the future for shares of our common stock, and they could deter potential acquirers of our company, thereby reducing the likelihood that holders of our common stock would receive a premium for their shares of our common stock in an acquisition. Our amended and restated certificate of incorporation that will become effective immediately prior to the closing of this offering will provide that the Court of Chancery of the State of Delaware and the federal district court for the District of Delaware of the United States will be the exclusive forums for substantially all disputes between us and our stockholders, which could limit our stockholders’ ability to obtain a favorable judicial forum for disputes with us or our directors,